Susquehanna International Group, LLP Acer Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.57 - $1.28 $165,512 - $371,676	290,372 New	290,372 $238,000
Q3 2022 Nov 14, 2022	BUY	$1.28 - $1.6 $20,727 - $25,908	16,193 New	16,193 $23,000
Q4 2021 Feb 14, 2022	SELL	$1.88 - $2.9 $22,936 - $35,380	-12,200 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.3 - $2.86 $15,688 - $19,508	-6,821 Reduced 35.86%	12,200 $31,000
Q2 2021 Aug 11, 2021	SELL	$2.52 - $3.18 $6,851 - $8,646	-2,719 Reduced 12.51%	19,021 $54,000
Q1 2021 May 17, 2021	BUY	$2.47 - $4.39 $53,697 - $95,438	21,740 New	21,740 $68,000
Q2 2019 Aug 14, 2019	SELL	$3.45 - $26.86 $84,949 - $661,373	-24,623 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$20.4 - $25.15 $252,266 - $311,004	12,366 Added 100.89%	24,623 $598,000
Q4 2018 Feb 14, 2019	BUY	$16.55 - $30.22 $202,853 - $370,406	12,257 New	12,257 $247,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.